Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve, Inc. is a Canada-based healthcare technology company. The Company has two business units: Medivolve Pharmacy Division (MPD) and Collection Sites Diagnostics (CSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine, and psychiatry to patients in Southern California. CSD’s software platform, Electronic Health Records app (EHR), is focused on supporting clinical staff, is a series of assets and functionalities that enhance the customer experience and provide an end-to-end lab solution. The Company, through its subsidiaries, Medivolve Pharmacy Inc., and Kedy Ying Jao D.O., a medical corporation, operate a distributed network of two retail patient-care locations in California, United States. The Company has served hundreds of thousands of patients across the United States and facilitated more than 1,533,000 clinical tests.


OTCPK:MEDVF - Post by User

Comment by Sarb99on Nov 09, 2020 10:36am
146 Views
Post# 31862514

RE:RE:Vaccine

RE:RE:VaccineVaccine won’t be available for everyone, only 50 million will be available globally this year and 1.3 billion next year. So, testing still going to highly needed.
 
As QuestCap is planning to offer vaccination service whenever vaccine is available. I think QuestCap is in best position either way or offer both at same time.



Even if "some Americans are vaccinated later this year, it will be many more months before there is widespread vaccination in this country," Biden said in a statement. "Today's news does not change this urgent reality. Americans will have to rely on masking, distancing, contact tracing, hand washing, and other measures to keep themselves safe well into next year."

Pfizer said that based on current projections it expects to produce globally up to 50 million vaccine doses in 2020 and up to 1.3 billion doses in 2021.

https://www.nbcnews.com/health/health-news/covid-19-vaccine-90-percent-effective-first-analysis-pfizer-says-n1247075


Bermudashorts10 wrote: Testing will still be required regardless of vaccine. Plus I expect they will try to pivot at some point to offer both testing and vaccinations sometime next year 


<< Previous
Bullboard Posts
Next >>